# EDGAR Filing Document

**Accession Number:** 0001051219
**File Stem:** 0001162044-26-000365
**Filing Date:** 2026-4
**Character Count:** 20568
**Document Hash:** 33533ce7606bb7a9240b681e25f3133e
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001162044-26-000365.hdr.sgml**: 20260428

**ACCESSION NUMBER**: 0001162044-26-000365

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260428

**DATE AS OF CHANGE**: 20260428

**PERIOD START**: 20261130

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** TANAKA FUNDS INC
- **CENTRAL INDEX KEY:** 0001051219

**ORGANIZATION NAME:**
- **EIN:** 541891278
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 1130

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08683
- **FILM NUMBER:** 26905443

**BUSINESS ADDRESS:**
- **STREET 1:** 777 WEST PUTNAM AVENUE
- **STREET 2:** SUITE 300
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830
- **BUSINESS PHONE:** 2124903380

**MAIL ADDRESS:**
- **STREET 1:** 777 WEST PUTNAM AVENUE
- **STREET 2:** SUITE 300
- **CITY:** GREENWICH
- **STATE:** CT
- **ZIP:** 06830

## Series and Classes Contracts Data

### TANAKA Growth Fund (Series ID: S000004755)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000012945 | Class R      | TGFRX           |

## Nport-Ex

---

| | | |
|:---|:---|:---|
| **Schedule of Investments** | **Schedule of Investments** | **Schedule of Investments** |
| **February 27, 2026 (unaudited)** | **February 27, 2026 (unaudited)** | **February 27, 2026 (unaudited)** |
| **<u>Tanaka Growth Fund</u>** | **<u>Tanaka Growth Fund</u>** | **<u>Tanaka Growth Fund</u>** |
|  | **Shares or Principal** |  |
| **Security Description** | **Amount ($)** | **Fair Value ($)(1)** |
| **Common Stocks - 85.81%** | **Common Stocks - 85.81%** | **Common Stocks - 85.81%** |
| **Accident & Health Insurance - 2.52%** |  |  |
| Aflac, Inc. | 8290  | 936190  |
| **Asset Management - 2.36%** |  |  |
| The Carlyle Group, Inc. | 16875  | 877331  |
| **Base Metals - 7.82%** |  |  |
| United States Antimony Corp. (2) | 325000  | 2905500  |
| **Beverages - 2.40%** |  |  |
| PepsiCo, Inc. | 5250  | 891135  |
| **Biotech - 11.43%** |  |  |
| Intellia Therapeutics, Inc. (2) | 100000  | 1378000  |
| Nuvation Bio, Inc. (2) | 485000  | 2866350  |
|  |  | 4244350  |
| **Credit Services - 1.75%** |  |  |
| Mastercard, Inc. | 1260  | 651685  |
| **Electronic Computers - 4.67%** |  |  |
| Apple, Inc.  | 6563  | 1733813  |
| **General Industrial Machinery & Equipment - 3.32%** |  |  |
| Symbotic, Inc. (2) | 22500  | 1232550  |
| **Internet Media & Services - 1.33%** |  |  |
| Meta Platforms, Inc. Class A  | 760  | 492617  |
| **Measuring & Controlling Device - 3.05%** |  |  |
| Onto Innovation, Inc. (2) | 5253  | 1134070  |
| **Miscellaneous Metal Ores - 17.40%** |  |  |
| Aura Minerals, Inc. (British Virgin Islands) (2) # | 28250  | 2385713  |
| Cameco Corp. (Canada) # | 8800  | 1041920  |
| NexGen Energy Ltd. (Canada) (2) # | 190889  | 2436881  |
| Uranium Energy Corp. (2) | 39000  | 597870  |
|  |  | 6462384  |
| **Pharmaceutical Preparations - 8.29%** |  |  |
| Catalyst Pharmaceuticals, Inc. (2) | 52255  | 1865504  |
| Corcept Therapeutics, Inc. (2) | 52598  | 1213962  |
|  |  | 3079465  |
| **Radio & TV Broadcasting & Communications Equipment - 1.81%** |  |  |
| QUALCOMM, Inc. | 4723  | 672366  |
| **Renewable Energy Equipment - 2.65%** |  |  |
| Electrovaya, Inc. (Canada) (2) # | 130000  | 982800  |
| **Retail-Catalog & Mail-Order Houses - 2.11%** |  |  |
| Amazon.com, Inc. (2) | 3730  | 783300  |
| **Security Brokers, Dealers & Flotation Companies - 2.38%** |  |  |
| Stifel Financial Corp. | 11940  | 884157  |
| **Semiconductors & Related Devices - 10.53%** |  |  |
| Applied Materials, Inc. | 3870  | 1440801  |
| NVIDIA Corp. | 13950  | 2471801  |
|  |  | 3912602  |
| Total Common Stock | (Cost $12,008,108) | 31876315  |
| **Short-Term Investments - 14.09%** | **Short-Term Investments - 14.09%** | **Short-Term Investments - 14.09%** |
| Huntington Conservative Deposit Account - 3.54% (3) | 5234502  | 5234502  |
| Total Short-Term Investment Companies | (Cost $5,234,502) | 5234502  |
| **Total Investments - 99.91%** | (Cost $17,242,611) | 37110817  |
| Other Assets Less Liabilities - 0.09% |  | 34624  |
| Total Net Assets - 100.00% |  | 37145441  |
| (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. | (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. | (1) ***Statement on Financial Accounting Standard No. 157 "Fair Value Measurements"*** - Various inputs are used in determining the value of the Fund's investments. |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;These inputs are summarized in the three broad levels listed below. |
| • Level 1 - quoted prices in active markets for identical securities | • Level 1 - quoted prices in active markets for identical securities | • Level 1 - quoted prices in active markets for identical securities |
| • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) | • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) | • Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.) |
| • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) | • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) | • Level 3 - significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of February 27, 2026 in valuing the Fund's assets carried at fair value: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of February 27, 2026 in valuing the Fund's assets carried at fair value: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the inputs used as of February 27, 2026 in valuing the Fund's assets carried at fair value: |
|  | Investments in  | Other Financial |
| Valuation Inputs | Securities | Instruments (9) |
| Level 1 - Quoted Prices | $37110817 | - |
| Level 2 - Other Significant Observable Inputs | -  | - |
| Level 3 - Significant Unobservable Inputs | -  | - |
| Total | $37110817 | - |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. For example, short-term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;debt instruments and repurchase agreements with a maturity of less than 60 days are valued using amortized cost, in accordance with rules under the Investment |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Company Act of 1940. Generally, amortized cost approximates the current fair value of a security, but since the value is not obtained from a quoted price in an active |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;market, such securities are reflected as Level 2. |
| (2) Represents non-income producing securities. | (2) Represents non-income producing securities. | (2) Represents non-income producing securities. |
| (3) The Conservative Deposit Account ("CDA") is a short-term investment vehicle in which the Fund holds cash balances. The  | (3) The Conservative Deposit Account ("CDA") is a short-term investment vehicle in which the Fund holds cash balances. The  |  |
| CDA will bear interest at a variable rate that is determined based on conditions and may change daily and by any amount.The  | CDA will bear interest at a variable rate that is determined based on conditions and may change daily and by any amount.The  |  |
| coupon rate shown represents the yield at February 27, 2026. |  |  |
| # Total value for foreign common stock is $6,847,314, representing 18.43% of net assets.  | # Total value for foreign common stock is $6,847,314, representing 18.43% of net assets.  | # Total value for foreign common stock is $6,847,314, representing 18.43% of net assets.  |

---

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** TANAKA FUNDS INC

- **b. Investment Company Act file number:** 811-08683

- **c. CIK number of Registrant:** 0001051219

- **d. LEI of Registrant:** 54930073LAPJDABRWN22

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 777 West Putnam Avenue

  - **City:** Greenwich

  - **State:** CT

  - **Foreign country:** US

  - **Zip / Postal Code:** 06830

  - **Telephone number:** 212-490-3380

**Item A.2. Information about the Series.**

- **a. Name of Series:** Tanaka Growth Fund

- **b. EDGAR series identifier (if any):** S000004755

- **c. LEI of Series:** 54930042064FVO6TG342

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-11-30

- **b. Date as of which information is reported:** 2026-02-28

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $37199592.05

**Total Liabilities:** $54150.69

**Net Assets:** $37145441.36

**Cash Not Reported:** $5234502.38

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000012945 | -5.05%               | 5.74%                | 1.18%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $-1878707.15                               |
| Month 2  | $225204.83               | $1711511.44                                |
| Month 3  | $0.00                    | $461321.51                                 |

### Schedule of Portfolio Investments

| Name                           | Title                          | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Aflac, Inc.                    | Aflac, Inc.                    | CUSIP: 001055102<br>LEI: 549300N0B7DOGLXWPP39 | Long             | EC               | CORP              | US        |      8290 | NS      | $936189.70    | 2.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Amazon.com, Inc.               | Amazon.com, Inc.               | CUSIP: 023135106<br>LEI: ZXTILKJKG63JELOEG630 | Long             | EC               | CORP              | US        |      3730 | NS      | $783300.00    | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Apple, Inc.                    | Apple, Inc.                    | CUSIP: 037833100<br>LEI: HWUPKR0MPOU8FGXBT394 | Long             | EC               | CORP              | US        |      6563 | NS      | $1733813.34   | 4.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Applied Materials, Inc.        | Applied Materials, Inc.        | CUSIP: 038222105<br>LEI: 41BNNE1AFPNAZELZ6K07 | Long             | EC               | CORP              | US        |      3870 | NS      | $1440801.00   | 3.88%             |  |  |  | No            |                  1 | On Loan: No      |
| Aura Minerals, Inc.            | Aura Minerals, Inc.            | CUSIP: G06973112<br>LEI: 549300YIRI8PSDM2FV20 | Long             | EC               | CORP              | VI        |     28250 | NS      | $2385712.50   | 6.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Blue Earth Refineries, Inc.    | Blue Earth Refineries, Inc.    | CUSIP: G11999102<br>LEI: 549300TO81ENOHW1NK80 | Long             | EC               | CORP              | US        |     27719 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Cameco Corp.                   | Cameco Corp.                   | CUSIP: 13321L108<br>LEI: N4BHALMXL3GMZKCUON55 | Long             | EC               | CORP              | CA        |      8800 | NS      | $1041920.00   | 2.80%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |     52598 | NS      | $1213961.84   | 3.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics, Inc.     | Corcept Therapeutics, Inc.     | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |     52255 | NS      | $1865503.50   | 5.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Electrovaya, Inc.              | Electrovaya, Inc.              | CUSIP: 28617B606<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |    130000 | NS      | $982800.00    | 2.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Intellia Therapeutics, Inc.    | Intellia Therapeutics, Inc.    | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |    100000 | NS      | $1378000.00   | 3.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Mastercard, Inc.               | Mastercard, Inc.               | CUSIP: 57636Q104<br>LEI: AR5L2ODV9HN37376R084 | Long             | EC               | CORP              | US        |      1260 | NS      | $651684.60    | 1.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Meta Platforms, Inc.           | Meta Platforms, Inc. Class A   | CUSIP: 30303M102<br>LEI: BQ4BKCS1HXDV9HN80Z93 | Long             | EC               | CORP              | US        |       760 | NS      | $492616.80    | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| NVIDIA Corp.                   | NVIDIA Corp.                   | CUSIP: 67066G104<br>LEI: 549300S4KLFTLO7GSQ80 | Long             | EC               | CORP              | US        |     13950 | NS      | $2471800.50   | 6.65%             |  |  |  | No            |                  1 | On Loan: No      |
| NexGen Energy Ltd.             | NexGen Energy Ltd.             | CUSIP: GSCAC9633<br>LEI: 529900N0IXNXB3IP7F06 | Long             | EC               | CORP              | CA        |    190889 | NS      | $2436881.34   | 6.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio, Inc.             | Nuvation Bio, Inc.             | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    485000 | NS      | $2866350.00   | 7.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Onto Innovation, Inc.          | Onto Innovation, Inc.          | CUSIP: 683344105<br>LEI: 549300V1USTYXJ7TNR79 | Long             | EC               | CORP              | US        |      5253 | NS      | $1134070.17   | 3.05%             |  |  |  | No            |                  1 | On Loan: No      |
| PepsiCo, Inc.                  | PepsiCo, Inc.                  | CUSIP: 713448108<br>LEI: FJSUNZKFNQ5YPJ5OT455 | Long             | EC               | CORP              | US        |      5250 | NS      | $891135.00    | 2.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Qualcomm, Inc.                 | Qualcomm, Inc.                 | CUSIP: 747525103<br>LEI: H1J8DDZKZP6H7RWC0H53 | Long             | EC               | CORP              | US        |      4723 | NS      | $672366.28    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Stifel Financial Corp.         | Stifel Financial Corp.         | CUSIP: 860630102<br>LEI: 549300E5F07FE5GHJX84 | Long             | EC               | CORP              | US        |     11940 | NS      | $884157.00    | 2.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Symbotic, Inc.                 | Symbotic, Inc. Class A         | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | US        |     22500 | NS      | $1232550.00   | 3.32%             |  |  |  | No            |                  1 | On Loan: No      |
| The Carlyle Group, Inc.        | The Carlyle Group, Inc.        | CUSIP: 14309L102<br>LEI: 529900NGGVF94UK6PG95 | Long             | EC               | CORP              | US        |     16875 | NS      | $877331.25    | 2.36%             |  |  |  | No            |                  1 | On Loan: No      |
| United States Antimony Corp.   | United States Antimony Corp.   | CUSIP: 911549103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    325000 | NS      | $2905500.00   | 7.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Uranium Energy Corp.           | Uranium Energy Corp.           | CUSIP: 916896103<br>LEI: 549300VD69WD2USLIP04 | Long             | EC               | CORP              | US        |     39000 | NS      | $597870.00    | 1.61%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-02-27

**Name of Applicant:** Tanaka Funds Inc

**Signature:** /s/ Graham Tanaka

**Name of Signer:** Graham Tanaka

**Title:** President